Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 22, 2021
Event: Entry into a Material Definitive Agreement to refinance its Asset-Based Lending (ABL) facility.
Key Financial Metrics and Debt Structure
This filing details a new credit facility rather than reporting operational financial results (revenue, profit, or cash flow). Key debt metrics include:
- New Facility Size: $1,000,000,000 revolving asset-based loan facility (subject to borrowing base capacity).
- Letters of Credit: Up to $200,000,000 available within the facility.
- Maturity Date: November 22, 2026 (5-year term).
- Interest Rates (Applicable Margin):
- Base Rate: 0.75%, 1.00%, or 1.25% per annum.
- SOFR Rate: 1.75%, 2.00%, or 2.25% per annum.
- Commitment Fee: 0.25% or 0.375% per annum on the unused portion.
- Collateral: First-priority security interest in accounts receivable and related assets; junior-priority third lien on other assets.
Material Changes Versus Prior Period
The Company replaced its existing ABL Credit Agreement dated April 3, 2018, with the new Amended and Restated ABL Credit Agreement. The filing does not provide comparative financial performance data (e.g., revenue or net income changes) as this is a transactional report.
Outlook, Risks, and Contingencies
- Springing Maturity: The facility includes a 91-day springing maturity provision if more than $350 million in aggregate principal of specific senior notes (due 2025, 2026, or 2027) or refinancings thereof become due prior to November 22, 2026.
- Covenants: The agreement contains standard negative and affirmative covenants, events of default, and repayment provisions typical for asset-based facilities.
- Guarantees: Obligations are guaranteed by the Company and all domestic subsidiaries that guarantee other outstanding senior indebtedness.
Investor Verification Checklist
- Verify the current "borrowing base capacity" to determine the actual available liquidity versus the $1 billion commitment.
- Review the status of the Company's senior notes (6.625% due 2025, 8.000% due 2026, 5.625% due 2027) to assess the risk of triggering the 91-day springing maturity.
- Confirm the Company's compliance with the new negative and affirmative covenants outlined in Exhibit 10.1.
- Check subsequent filings for any utilization of the new facility or changes in the borrowing base.